Oral Cancer: Clinical Guidelines, Liability Trends and Risk Management
This webinar is presented by Dentist’s Advantage, NSDP and CNA.
Oral squamous cell carcinoma (OSCC) is an aggressive epithelial malignancy that is the sixth most common neoplasm in the world today. Despite numerous advances in treatment the long-term survival has remained ~55%. This poor long-term survival is due to a number of factors including delayed diagnosis and the development of multiple primary tumors. Therefore, the early detection and prevention of all premalignant lesions is critical for the long-term survival of these patients.
Mark W. Lingen, DDS, PhD, FRCPath, Professor of Pathology, Medicine and Radiation & Cellular Oncology at the University of Chicago, Pritzker School of Medicine
Ronald R. Zentz, RPh, DDS, FAGD, CPHRM, Dental Risk Control Consulting Director, CNA Healthcare
Continuing education credit is only available for those who attended the live event.
Register and listen to recording